Global Antibody-drug Conjugate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152709
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells.

Scope of the Report:

The worldwide market for Antibody-drug Conjugate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Antibody-drug Conjugate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Agensys

Concortis Biotherapeutics

Sanofi

Celldex Therapeutics

Synthon Holding BV

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Adcetris

Kadcyla

Market Segment by Applications, can be divided into

Breast Cancer

Lymphoma

There are 15 Chapters to deeply display the global Antibody-drug Conjugate market.

Chapter 1, to describe Antibody-drug Conjugate Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antibody-drug Conjugate, with sales, revenue, and price of Antibody-drug Conjugate, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibody-drug Conjugate, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antibody-drug Conjugate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antibody-drug Conjugate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Antibody-drug Conjugate Introduction

1.2 Market Analysis by Type

1.2.1 Adcetris

1.2.2 Kadcyla

1.3 Market Analysis by Applications

1.3.1 Breast Cancer

1.3.2 Lymphoma

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Agensys

2.1.1 Business Overview

2.1.2 Antibody-drug Conjugate Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Agensys Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Concortis Biotherapeutics

2.2.1 Business Overview

2.2.2 Antibody-drug Conjugate Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi

2.3.1 Business Overview

2.3.2 Antibody-drug Conjugate Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celldex Therapeutics

2.4.1 Business Overview

2.4.2 Antibody-drug Conjugate Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Synthon Holding BV

2.5.1 Business Overview

2.5.2 Antibody-drug Conjugate Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antibody-drug Conjugate Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Antibody-drug Conjugate Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Antibody-drug Conjugate Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Antibody-drug Conjugate Manufacturer Market Share in 2017

3.3.2 Top 6 Antibody-drug Conjugate Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Antibody-drug Conjugate Market Analysis by Regions

4.1 Global Antibody-drug Conjugate Sales, Revenue and Market Share by Regions

4.1.1 Global Antibody-drug Conjugate Sales and Market Share by Regions (2013-2018)

4.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Regions (2013-2018)

4.2 North America Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

4.3 Europe Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

4.5 South America Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

5 North America Antibody-drug Conjugate by Countries

5.1 North America Antibody-drug Conjugate Sales, Revenue and Market Share by Countries

5.1.1 North America Antibody-drug Conjugate Sales and Market Share by Countries (2013-2018)

5.1.2 North America Antibody-drug Conjugate Revenue and Market Share by Countries (2013-2018)

5.2 United States Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

5.3 Canada Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

5.4 Mexico Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

6 Europe Antibody-drug Conjugate by Countries

6.1 Europe Antibody-drug Conjugate Sales, Revenue and Market Share by Countries

6.1.1 Europe Antibody-drug Conjugate Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Antibody-drug Conjugate Revenue and Market Share by Countries (2013-2018)

6.2 Germany Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

6.3 UK Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

6.4 France Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

6.5 Russia Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

6.6 Italy Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

7 Asia-Pacific Antibody-drug Conjugate by Countries

7.1 Asia-Pacific Antibody-drug Conjugate Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Antibody-drug Conjugate Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Antibody-drug Conjugate Revenue and Market Share by Countries (2013-2018)

7.2 China Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

7.3 Japan Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

7.4 Korea Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

7.5 India Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

8 South America Antibody-drug Conjugate by Countries

8.1 South America Antibody-drug Conjugate Sales, Revenue and Market Share by Countries

8.1.1 South America Antibody-drug Conjugate Sales and Market Share by Countries (2013-2018)

8.1.2 South America Antibody-drug Conjugate Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

8.3 Argentina Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

8.4 Colombia Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

9 Middle East and Africa Antibody-drug Conjugate by Countries

9.1 Middle East and Africa Antibody-drug Conjugate Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Antibody-drug Conjugate Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Antibody-drug Conjugate Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

9.3 UAE Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

9.4 Egypt Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

9.5 Nigeria Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

9.6 South Africa Antibody-drug Conjugate Sales and Growth Rate (2013-2018)

10 Global Antibody-drug Conjugate Market Segment by Type

10.1 Global Antibody-drug Conjugate Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Antibody-drug Conjugate Sales and Market Share by Type (2013-2018)

10.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Type (2013-2018)

10.2 Adcetris Sales Growth and Price

10.2.1 Global Adcetris Sales Growth (2013-2018)

10.2.2 Global Adcetris Price (2013-2018)

10.3 Kadcyla Sales Growth and Price

10.3.1 Global Kadcyla Sales Growth (2013-2018)

10.3.2 Global Kadcyla Price (2013-2018)

11 Global Antibody-drug Conjugate Market Segment by Application

11.1 Global Antibody-drug Conjugate Sales Market Share by Application (2013-2018)

11.2 Breast Cancer Sales Growth (2013-2018)

11.3 Lymphoma Sales Growth (2013-2018)

12 Antibody-drug Conjugate Market Forecast (2018-2023)

12.1 Global Antibody-drug Conjugate Sales, Revenue and Growth Rate (2018-2023)

12.2 Antibody-drug Conjugate Market Forecast by Regions (2018-2023)

12.2.1 North America Antibody-drug Conjugate Market Forecast (2018-2023)

12.2.2 Europe Antibody-drug Conjugate Market Forecast (2018-2023)

12.2.3 Asia-Pacific Antibody-drug Conjugate Market Forecast (2018-2023)

12.2.4 South America Antibody-drug Conjugate Market Forecast (2018-2023)

12.2.5 Middle East and Africa Antibody-drug Conjugate Market Forecast (2018-2023)

12.3 Antibody-drug Conjugate Market Forecast by Type (2018-2023)

12.3.1 Global Antibody-drug Conjugate Sales Forecast by Type (2018-2023)

12.3.2 Global Antibody-drug Conjugate Market Share Forecast by Type (2018-2023)

12.4 Antibody-drug Conjugate Market Forecast by Application (2018-2023)

12.4.1 Global Antibody-drug Conjugate Sales Forecast by Application (2018-2023)

12.4.2 Global Antibody-drug Conjugate Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Antibody-drug Conjugate Picture

Table Product Specifications of Antibody-drug Conjugate

Figure Global Sales Market Share of Antibody-drug Conjugate by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery